Healthcare -
Biotechnology - NASDAQ - US
$ 1.2229
-0.84 %
$ 18.5 M
Market Cap
-0.87
P/E
LGVN - CASH & EQUIVALENTS
Cash & Equivalents LGVN - Longeveron Inc.
19.2 M
LAST VALUE
35.32%
2 YEAR CAGR
59.45%
5 YEAR CAGR
0.00%
10 YEAR CAGR